ITI Pharma and Healthcare Fund Regular vs Nippon India Pharma Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High Risk |
Asset Size (Cr) | ₹217 Cr | ₹8161 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.35 | 1.82 |
Manager | Rohan Korde | Sailesh Raj Bhan |
ISIN Code | INF00XX01BL5 | INF204K01968 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | -7.34% | -6% |
6 Month | -6.6% | -8.47% |
1 Year | 9.8% | 6.77% |
3 Year | 17.76% | 18.71% |
5 Year | - | 22.93% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | - | - |
1 Year | 0.71% | -1.87% |
3 Year | 20.99% | 21.17% |
5 Year | - | 19.06% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 24.79% | 18.19% |
3 Year | 19.26% | 20.5% |
5 Year | - | 20.36% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 15.667% | 15.185% |
Sharp | 0.739% | 0.81% |
Beta | 0.959% | 0.931% |
Alpha | -1.413% | -0.33% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Rohan Korde | Sailesh Raj Bhan |
Total AUM | ₹4626 Cr | ₹96086 Cr |
Fund Manage | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.8 | 4.4 |
Large Cap | 38.11 | 45.96 |
Mid Cap | 26.43 | 27.12 |
Small Cap | 33.66 | 22.52 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.8 | 4.4 |
Pharmaceuticals & Biotechnology | 77 | 75.86 |
Healthcare Services | 18.01 | 17.38 |
Chemicals & Petrochemicals | 0.96 | - |
Fertilizers & Agrochemicals | 1.03 | - |
Insurance | 1.2 | - |
Retailing | - | 2.36 |
Top Comparisons
IDBI Nifty Next 50 Index Fund Growth
3Y Returns14.38%
LIC MF NIFTY NEXT 50 INDEX FUND Regular Growth
3Y Returns14.38%
Nippon India Power & Infra Fund-Growth Plan -Growth Option
3Y Returns27.06%
Tata Infrastructure Fund-Regular Plan- Growth Option
3Y Returns18.62%
ICICI Prudential Ultra Short Term Fund - Growth
3Y Returns6.44%
Aditya Birla Sun Life Savings Fund - Growth - Regular Plan
3Y Returns6.7%
Aditya Birla Sun Life Equity Hybrid 95 Fund - Regular Plan-Growth
3Y Returns8.47%
Tata Hybrid Equity Fund- Regular Plan - Growth Option
3Y Returns10.4%